Treatment guidelines and patterns of care in oral cavity squamous cell carcinoma: Primary surgical resection vs. nonsurgical treatment

被引:23
|
作者
Fujiwara, Rance J. T. [1 ]
Burtness, Barbara [2 ,3 ]
Husain, Zain A. [2 ,4 ]
Judson, Benjamin L. [1 ,2 ]
Bhatia, Aarti [2 ,3 ]
Sasaki, Clarence T. [1 ,2 ]
Yarbrough, Wendell G. [1 ,2 ,5 ]
Mehra, Saral [1 ,2 ]
机构
[1] Yale Univ, Sch Med, Dept Surg Otolaryngol, New Haven, CT USA
[2] Yale Canc Ctr, New Haven, CT USA
[3] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA
[4] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA
[5] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
关键词
Oral cancer; Squamous cell carcinoma; Guideline adherence; Health services; Quality of care; MISSING DATA; CANCER; SURVIVAL; HEAD; OUTCOMES; SURGERY; BASE; EFFICACY; ADJUVANT; THERAPY;
D O I
10.1016/j.oraloncology.2017.06.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The 2017 National Comprehensive Cancer Network Clinical Practice Guidelines recommend surgical resection or definitive radiation therapy for early-stage oral cavity malignancies, and surgical resection or multimodality clinical trials for late-stage disease. Few studies have been conducted to identify predictors of choice of treatment modality for oral cavity malignancies. Methods: All patients in the National Cancer Data Base (NCDB) diagnosed with oral cavity squamous cell carcinoma (OCSCC) between 1998 and 2011 were identified. Chi-square and binary logistic regression were used to identify factors predictive of surgical or nonsurgical treatment; multiple imputation was used for missing data. Cox proportional hazards models were generated to identify associations between treatment modality and overall survival (OS). Results: Of 23,459 patients, 4139 (17.6%) underwent primary nonsurgical treatment. Among NCDBregistered facilities, there has been a decrease in use of nonsurgical treatment for OCSCC (OR 0.97, p < 0.001). Older age, non-white race, Medicaid insurance, low income, low education, and later-stage disease were associated with nonsurgical therapy, while patients at academic/research programs were more likely to undergo surgery (OR 0.38, p < 0.001). Nonsurgical treatment was associated with decreased OS (HR = 2.02, p < 0.001); this was upheld on subgroup analysis of early-and late-stage disease. Conclusions: Use of primary nonsurgical treatment for OCSCC has decreased over time among NCDBregistered facilities and is associated with factors related to access to care. Surgical resection for the primary treatment of oral cavity cancer may be associated with improved OS, though conclusions regarding survival are limited by the non-randomized nature of the data. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:129 / 137
页数:9
相关论文
共 50 条
  • [1] Surgical treatment options for squamous cell carcinoma of the oral cavity
    Rasse, Michael
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2008, 158 (9-10) : 243 - 248
  • [2] Surgical vs Nonsurgical Treatment of Basal Cell Carcinoma
    Aguayo-Leiva, I. R.
    Rios-Buceta, L.
    Jaen-Olasolo, P.
    ACTAS DERMO-SIFILIOGRAFICAS, 2010, 101 (08): : 683 - 692
  • [3] Primary site surgical resection in cM1 oral cavity squamous cell carcinoma
    Patel, Aman M.
    Haleem, Afash
    Revercomb, Lucy
    Brant, Jason A.
    Rajasekaran, Karthik
    Sun, Lova L.
    Brody, Robert M.
    Carey, Ryan M.
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2024, 9 (05):
  • [4] Surgical vs Nonsurgical Treatment Modalities for T3 Glottic Squamous Cell Carcinoma
    Al-Gilani, Maha
    Skillington, S. Andrew
    Kallogjeri, Dorina
    Haughey, Bruce
    Piccirillo, Jay F.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2016, 142 (10) : 940 - 946
  • [5] TREATMENT OF SQUAMOUS CELL-CARCINOMA OF ORAL CAVITY
    FAYOS, JV
    LAMPE, I
    AMERICAN JOURNAL OF SURGERY, 1972, 124 (04): : 493 - +
  • [6] Survival after curative surgical treatment for primary oral squamous cell carcinoma
    Bloebaum, M.
    Poort, L.
    Bockmann, R.
    Kessler, P.
    JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2014, 42 (08) : 1572 - 1576
  • [7] Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, and Larynx: A Scoping Review of Treatment Guidelines Worldwide
    Arboleda, Lady Paola Aristizabal
    de Carvalho, Genival Barbosa
    Santos-Silva, Alan Roger
    Fernandes, Gisele Aparecida
    Vartanian, Jose Guilherme
    Conway, David I.
    Virani, Shama
    Brennan, Paul
    Kowalski, Luiz Paulo
    Curado, Maria Paula
    CANCERS, 2023, 15 (17)
  • [8] Salvage treatment for recurrent squamous cell carcinoma of the oral cavity
    Schwartz, GJ
    Mehta, RH
    Wenig, BL
    Shaligram, C
    Portugal, LG
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2000, 22 (01): : 34 - 41
  • [9] Treatment effects in patients with squamous cell carcinoma of the oral cavity
    Inagi, K
    Takahashi, H
    Okamoto, M
    Nakayama, M
    Makoshi, T
    Nagai, H
    ACTA OTO-LARYNGOLOGICA, 2002, 122 : 25 - 29
  • [10] Efficacy of acitretin in the treatment of squamous cell carcinoma of the oral cavity
    Carlesimo, Marta
    Narcisi, Alessandra
    Abruzzese, Claudia
    Orsini, Diego
    Cortesi, Giorgia
    Arcese, Annalisa
    Bartolazzi, Armando
    Camplone, Germana
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2011, 20 (05) : 429 - 430